Cargando…

Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders

Long-chain fatty acid oxidation disorders (lc-FAOD) are a group of diseases affecting the degradation of long-chain fatty acids. In order to investigate the disease specific alterations of the cellular lipidome, we performed undirected lipidomics in fibroblasts from patients with carnitine palmitoyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alatibi, Khaled I., Hagenbuchner, Judith, Wehbe, Zeinab, Karall, Daniela, Ausserlechner, Michael J., Vockley, Jerry, Spiekerkoetter, Ute, Grünert, Sarah C., Tucci, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157847/ https://www.ncbi.nlm.nih.gov/pubmed/34069977 http://dx.doi.org/10.3390/cells10051239

Ejemplares similares

Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders
por: Alatibi, Khaled I., et al.
Publicado: (2021)

Altered Metabolic Flexibility in Inherited Metabolic Diseases of Mitochondrial Fatty Acid Metabolism
por: Tucci, Sara, et al.
Publicado: (2021)

Very long-/ and long Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency correlates with deregulation of the mitochondrial fusion/fission machinery
por: Hagenbuchner, Judith, et al.
Publicado: (2018)

Mitochondria and FOXO3: breath or die
por: Hagenbuchner, Judith, et al.
Publicado: (2013)

Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD(−/−)) Mouse to Compensate a Defective Fatty Acid β-Oxidation
por: Tucci, Sara, et al.
Publicado: (2012)

3D bioprinting: novel approaches for engineering complex human tissue equivalents and drug testing
por: Hagenbuchner, Judith, et al.
Publicado: (2021)

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(−/−)) mice
por: Tucci, Sara, et al.
Publicado: (2014)

Heptanoate Improves Compensatory Mechanism of Glucose Homeostasis in Mitochondrial Long-Chain Fatty Acid Oxidation Defect
por: Nurjanah, Siti, et al.
Publicado: (2023)

A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration
por: Hagenbuchner, Judith, et al.
Publicado: (2013)

The Complex Interplay between Mitochondria, ROS and Entire Cellular Metabolism
por: Kuznetsov, Andrey V., et al.
Publicado: (2022)

Riboflavin 1 Transporter Deficiency: Novel SLC52A1 Variants and Expansion of the Phenotypic Spectrum
por: Grünert, Sarah C., et al.
Publicado: (2023)

Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease
por: Hannibal, Luciana, et al.
Publicado: (2020)

Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer
por: Hagenbuchner, Judith, et al.
Publicado: (2019)

Analysis of Mitochondrial Function, Structure, and Intracellular Organization In Situ in Cardiomyocytes and Skeletal Muscles
por: Kuznetsov, Andrey V., et al.
Publicado: (2022)

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders
por: Marsden, Deborah, et al.
Publicado: (2021)

Medium-chain acyl-CoA dehydrogenase deficiency associated with a novel splice mutation in the ACADM gene missed by newborn screening
por: Grünert, Sarah C., et al.
Publicado: (2015)

The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI
por: Grünert, Sarah Catharina, et al.
Publicado: (2021)

Reversible sensory neuropathy in mitochondrial trifunctional protein deficiency
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Crosstalk between Mitochondria and Cytoskeleton in Cardiac Cells
por: Kuznetsov, Andrey V., et al.
Publicado: (2020)

The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury
por: Kuznetsov, Andrey V., et al.
Publicado: (2019)

Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
por: Sklirou, Evgenia, et al.
Publicado: (2021)

Primary carnitine deficiency – diagnosis after heart transplantation: better late than never!
por: Grünert, Sarah C., et al.
Publicado: (2020)

The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastoma
por: Hagenbuchner, Judith, et al.
Publicado: (2017)

Successful pregnancy in a woman with glycogen storage disease type 6
por: Grünert, Sarah Catharina, et al.
Publicado: (2021)

Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa
por: Ausserlechner, Michael J., et al.
Publicado: (2013)

Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
por: Zöggeler, Thomas, et al.
Publicado: (2021)

Medium chain acyl-CoA dehydrogenase deficiency in a premature infant
por: Dobrowolski, Steven F., et al.
Publicado: (2017)

FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3
por: Rupp, M, et al.
Publicado: (2017)

Successful pregnancy in maple syrup urine disease: a case report and review of the literature
por: Grünert, Sarah Catharina, et al.
Publicado: (2018)

Evidence for a Genotype–Phenotype Correlation in Patients with Pathogenic GLUT2 (SLC2A2) Variants
por: Grünert, Sarah C., et al.
Publicado: (2021)

Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP)
por: Seiter, Maximilian A., et al.
Publicado: (2014)

Blood cytokine patterns suggest a modest inflammation phenotype in subjects with long‐chain fatty acid oxidation disorders
por: McCoin, Colin S., et al.
Publicado: (2019)

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma
por: Geiger, Kathrin, et al.
Publicado: (2012)

Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma
por: Hagenbuchner, Judith, et al.
Publicado: (2016)

Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants
por: Sturm, Marga, et al.
Publicado: (2012)

Improving diagnosis of mitochondrial fatty-acid oxidation disorders
por: Vianey-Saban, Christine, et al.
Publicado: (2023)

Impact of glycogen storage disease type I on adult daily life: a survey
por: Garbade, Sven F., et al.
Publicado: (2021)

C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma
por: Salcher, Stefan, et al.
Publicado: (2014)

Lengthening the Guanidine–Aryl Linker of Phenylpyrimidinylguanidines Increases Their Potency as Inhibitors of FOXO3-Induced Gene Transcription
por: Kohoutova, Klara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0s5jgoh4u3rot4u27l2t6ba8r